Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation

Miner, PB

Miner, PB (reprint author), Oklahoma Fdn Digest Res, 1813 Coventry Lane, Oklahoma City, OK 73120 USA.

DRUG SAFETY, 2019; 42 (5): 603

Abstract

Plecanatide, a uroguanylin analog, activates the guanylate cyclase C receptors in the epithelial lining of the gastrointestinal tract in a pH-dependen......

Full Text Link